Hot Corner Insider Buffett Reports an $85 Million Buy January 17, 2024 Steve Strazza From the Desk of Steve Strazza and Alfonso DepablosThe largest insider buy on today’s list comes via Form 4 filings by Warren Buffett and Berkshire Hathaway.Buffett and Berkshire reported purchases in The Liberty SiriusXM Group for a total amount of $84,970,847. Read More
Hot Corner Insider CEO Frost Buys 1,000,000 OPK Shares January 16, 2024 Steve Strazza From the Desk of Steve Strazza and Alfonso DepablosThe largest insider buy on today’s list comes via a handful of filings by the CEO and chairman of OPKO Health $OPK, Phillip Frost.Frost reported a total purchase of 1,000,000 OPK shares, equivalent to $954,300. Read More
Hot Corner Insider Insiders Are Buying TLRY Shares January 16, 2024 Steve Strazza From the Desk of Steve Strazza and Alfonso DepablosThe largest insider buy on today’s list comes in the form of filings by the CEO, the CFO, and the global general counsel of Tilray Brands Inc $TLRY.Each filed Form 4s revealing combined purchases of TLRY shares in the total amount of $148,454. Read More
Hot Corner Insider Forbion Capital GP Kersten Reports a $26 Million DYN Buy January 11, 2024 Steve Strazza From the Desk of Steve Strazza and Alfonso DepablosThe largest insider buy on today’s list comes in a Form 4 filing by Dirk Kersten.Kersten, who is general partner at Forbion Capital Fund, reported a purchase of roughly $26 million in Dyne Therapeutics Inc $DYN. Read More
Hot Corner Insider Baker Bros Boosts Its KYMR, REPL Stakes January 10, 2024 Steve Strazza From the Desk of Steve Strazza and Alfonso DepablosThe largest insider buy on today’s list comes in a 13G filing by Baker Bros Advisors LP.The hedge fund increased its ownership position in Kymera Therapeutics Inc $KYMR from 9.2% to 10.8%. Read More
Hot Corner Insider Biotechnology Value Fund Ups Its KYMR Stake to 10% January 9, 2024 Steve Strazza From the Desk of Steve Strazza and Alfonso DepablosThe largest insider buy on today’s list comes in a 13G filing by Biotechnology Value Fund.The investment partnership increased its stake in Kymera Therapeutics Inc $KYMR from 8.45% to 10%. Read More
Hot Corner Insider CEO Wentworth Buys 10,000 WBA Shares January 8, 2024 Steve Strazza From the Desk of Steve Strazza and Alfonso DepablosThe largest insider buy on today’s list comes in a Form 4 filing by Timothy C. Wentworth, CEO of Walgreens Boots Alliance $WBA..Wentworth reported a purchase of 10,000 WBA shares, equivalent to $242,220. Read More
Hot Corner Insider Broadwood Partners Reports a $6.4 Million STAA Purchase January 8, 2024 Steve Strazza From the Desk of Steve Strazza and Alfonso DepablosThe largest insider buy on today’s list comes in a Form 4 filing by Broadwood Partners LP.The investment firm reported a purchase of roughly $6.4 million in STAAR Surgical Company $STAA. Read More
Hot Corner Insider Point72 Takes a 5.4% Stake in CCCC January 4, 2024 Steve Strazza From the Desk of Steve Strazza and Alfonso DepablosThe only transaction on today’s list comes in a 13G filed by Point72 Asset Management.The hedge fund revealed an initial stake of 5.40% in C4 Therapeutics Inc $CCCC. Read More
Hot Corner Insider Riposte Capital Raises Its SBOW Stake to 9.7% January 3, 2024 Steve Strazza From the Desk of Steve Strazza and Alfonso DepablosThe only transaction on today’s list comes in a 13G filed by Riposte Capital.The firm increased its stake in SilverBow Resources $SBOW from 7.75% to 9.70%. Read More
Hot Corner Insider Director Lynch Reports Another Large GSAT Purchase January 2, 2024 Steve Strazza From the Desk of Steve Strazza and Alfonso DepablosThe largest transaction on today’s list comes in a Form 4 filing by James F. Lynch, director of Globalstar Inc $GSAT.Lynch reported a purchase of GSAT shares with a total value of $963,700. Read More
Hot Corner Insider Venrock Healthcare Capital Reports a $6.4 Million KALV Purchase January 2, 2024 Steve Strazza From the Desk of Steve Strazza and Alfonso DepablosThe most significant transaction on today’s list comes in a Form 4 filing by Venrock Healthcare Capital Partners.The firm reported a purchase of roughly $6.4 million in KalVista Pharmaceuticals Inc $KALV. Read More